BUZZ-Revvity shares rise as annual profit forecast is raised and third-quarter results beat expectations

November 3 - ** Shares of medical device maker Revvity RVTY.N rose 9% to $165.2 in pre-market trading

** The company raised its full-year adjusted earnings per share guidance from the previous range of $5.30–$5.40 to $5.40–$5.45

** Full-year total revenue is expected to be approximately $2.86 billion, previously forecasted at $2.83 billion to $2.86 billion

** The report shows third quarter (link) revenue was $729 million, beating analysts' estimates of $698.15 million — data compiled by LSEG

** Life sciences business revenue rose 11% year-on-year, while diagnostics business revenue increased 4% compared to the same period last year

** Third quarter adjusted earnings per share (EPS) was $1.37, also higher than the expected $1.30

** Six out of nineteen analysts rate the stock as “buy” or higher, the rest as “hold”; the median price target is $155

** As of the close of the previous trading day, the stock had gained 56.7% year-to-date, while the S&P 500 Health Care Index rose 19.2% over the same period .SPXHC

(To facilitate non-English native speakers, Reuters offers automated translation of its reports into several languages. As automated translations may contain errors or lack needed context, Reuters does not guarantee the accuracy of the automated translation and provides it solely for reader convenience. Reuters accepts no liability for any damage or loss arising from the use of the automated translation feature.)